Virtus ETF Advisers LLC Autolus Therapeutics PLC Transaction History
Virtus ETF Advisers LLC
- $234 Million
- Q4 2024
A detailed history of Virtus ETF Advisers LLC transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 26,429 shares of AUTL stock, worth $51,272. This represents 0.03% of its overall portfolio holdings.
Number of Shares
26,429
Previous 20,348
29.89%
Holding current value
$51,272
Previous $73,000
15.07%
% of portfolio
0.03%
Previous 0.04%
Shares
13 transactions
Others Institutions Holding AUTL
# of Institutions
114Shares Held
160MCall Options Held
2.8KPut Options Held
89.9K-
Wellington Management Group LLP Boston, MA25.3MShares$49.2 Million0.01% of portfolio
-
Blackstone Inc New York, NY20.5MShares$39.7 Million0.24% of portfolio
-
Syncona Portfolio LTD Guernsey, Channel Islands, X016.6MShares$32.3 Million73.83% of portfolio
-
Deep Track Capital, LP Greenwich, CT14.2MShares$27.6 Million1.47% of portfolio
-
Avoro Capital Advisors LLC New York, NY9.91MShares$19.2 Million0.34% of portfolio
About Autolus Therapeutics plc
- Ticker AUTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 90,909,800
- Market Cap $176M
- Description
- Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...